J Hradec

8.4k total citations
105 papers, 1.2k citations indexed

About

J Hradec is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, J Hradec has authored 105 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 33 papers in Molecular Biology and 19 papers in Surgery. Recurrent topics in J Hradec's work include Heart Failure Treatment and Management (17 papers), RNA and protein synthesis mechanisms (15 papers) and Cardiovascular Function and Risk Factors (13 papers). J Hradec is often cited by papers focused on Heart Failure Treatment and Management (17 papers), RNA and protein synthesis mechanisms (15 papers) and Cardiovascular Function and Risk Factors (13 papers). J Hradec collaborates with scholars based in Czechia, Germany and Slovakia. J Hradec's co-authors include Tomáš Janota, John J.V. McMurray, J Král, J Marek, Robert S. McKelvie, Bertil Olofsson, Mark E. Dunlap, Jan Östergren, Christopher B. Granger and Peter Held and has published in prestigious journals such as Nature, Circulation and Biochemical Journal.

In The Last Decade

J Hradec

94 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Hradec Czechia 16 551 369 248 222 94 105 1.2k
O. Vesterqvist Sweden 20 461 0.8× 303 0.8× 244 1.0× 248 1.1× 114 1.2× 60 1.4k
J. Augustín Germany 19 274 0.5× 309 0.8× 316 1.3× 296 1.3× 89 0.9× 46 1.2k
Richard S. Shulman United States 15 342 0.6× 366 1.0× 263 1.1× 451 2.0× 100 1.1× 25 1.0k
Jin Q Kim South Korea 18 188 0.3× 161 0.4× 243 1.0× 247 1.1× 72 0.8× 55 1.1k
G. Neugebauer Germany 19 389 0.7× 128 0.3× 86 0.3× 123 0.6× 63 0.7× 43 1.0k
Egbert Scholtens Netherlands 23 344 0.6× 351 1.0× 131 0.5× 79 0.4× 34 0.4× 45 1.3k
A. K. Pedersen Denmark 17 543 1.0× 152 0.4× 60 0.2× 118 0.5× 72 0.8× 38 1.1k
Paulette A. Lyle United States 19 563 1.0× 256 0.7× 367 1.5× 76 0.3× 59 0.6× 42 1.3k
Anders Gustafson Sweden 21 256 0.5× 305 0.8× 671 2.7× 485 2.2× 96 1.0× 48 1.7k
Dariusz Sitkiewicz Poland 16 367 0.7× 371 1.0× 77 0.3× 188 0.8× 50 0.5× 67 1.1k

Countries citing papers authored by J Hradec

Since Specialization
Citations

This map shows the geographic impact of J Hradec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Hradec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Hradec more than expected).

Fields of papers citing papers by J Hradec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Hradec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Hradec. The network helps show where J Hradec may publish in the future.

Co-authorship network of co-authors of J Hradec

This figure shows the co-authorship network connecting the top 25 collaborators of J Hradec. A scholar is included among the top collaborators of J Hradec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Hradec. J Hradec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Málek, Filip, et al.. (2022). (Summary of 2021 ESC Guidelines for the diagnosis and treatment of heart failure). Cor et Vasa. 64(2). 121–162. 1 indexed citations
2.
Hradec, J. (2018). Pharmacological therapy for chronic heart failure. Vnitřní lékařství. 64(9). 853–859. 3 indexed citations
3.
Hradec, J. (2015). [Chronic heart failure].. PubMed. 154(6). 260–8. 1 indexed citations
4.
Hradec, J, Jan Bultas, & Michael Želı́zko. (2010). Stabilní angina pectoris. Doporučený diagnostický a léčebný postup České kardiologické společnosti. Cor et Vasa. 52(9). 543–561. 2 indexed citations
5.
Janota, Tomáš, et al.. (2010). Effect of Short-Term Maximal Exercise on BNP Plasma Levels inHealthy Individuals. Physiological Research. 59(4). 625–628. 14 indexed citations
6.
Janota, Tomáš, et al.. (2009). Natriuretic peptides – physiology, pathophysiology and clinical use in heart failure. Physiological Research. 58(2). 171–177. 28 indexed citations
7.
Špinar, Jindřich, et al.. (2007). Doporučení pro diagnostiku a léčbu srdečního selhání ČKS 2006. Cor et Vasa. 49(1). 1 indexed citations
8.
Melenovský, Vojtěch, Tomáš Štulc, Viktor Kožich, et al.. (2003). Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine. American Heart Journal. 146(1). 110A–115A. 20 indexed citations
9.
Melenovský, Vojtěch, Dan Wichterle, Jan Malík, et al.. (2002). Nitroglycerin Induced Syncope Occurs in Subjects with Delayed Phase Shift of Baroreflex Action. Pacing and Clinical Electrophysiology. 25(5). 828–832. 7 indexed citations
10.
Hradec, J, J Král, Tomáš Janota, et al.. (1999). Regression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog). The American Journal of Cardiology. 83(10). 1506–1509. 57 indexed citations
11.
Cífková, Renata, Jan Peleška, J Hradec, et al.. (1998). Valsartan and atenolol in patients with severe essential hypertension. Journal of Human Hypertension. 12(8). 563–567. 27 indexed citations
12.
Hradec, J, J Marek, J Král, et al.. (1993). Long-term echocardiographic follow-up of acromegalic heart disease. The American Journal of Cardiology. 72(2). 205–210. 35 indexed citations
13.
Stiborová, Marie, Eva Frei, Heinz H. Schmeiser, & J Hradec. (1990). Mechanism of formation and 32P-postlabeling of DNA adducts derived from peroxidative activation of carcinogenic non-aminoazo dye 1-phenylazo-2-hydroxynaphthalene (Sudan I). Carcinogenesis. 11(10). 1843–1848. 40 indexed citations
14.
Hradec, J & D Veselý. (1989). The initiator tRNA acceptance assay as a short-term test for carcinogens. 4. Results with 20 mycotoxins. Carcinogenesis. 10(1). 213–215. 4 indexed citations
15.
Hradec, J, B. Spiegelhalder, & R. Preußmann. (1988). The initiator tRNA acceptance assay as a short-term test for carcinogens. 3. Results with 69 N-nitroso compounds. Carcinogenesis. 9(5). 847–851. 1 indexed citations
17.
Hradec, J, et al.. (1971). Effect of cholesteryl 14‐methylhexadecanoate on the RNA polymerase activity of rat liver nuclei in vivo and in vitro. FEBS Letters. 18(1). 109–111. 3 indexed citations
18.
Hradec, J, et al.. (1971). The role of cholesteryl 14-methylhexadecanoate in peptide elongation reactions. Biochemical Journal. 123(5). 959–966. 31 indexed citations
19.
Hradec, J, et al.. (1970). Effect of cholesteryl esters with different saturated fatty acids on aminoacyl‐tRNA synthesis in rat liver. FEBS Letters. 9(3). 161–162. 6 indexed citations
20.
Hradec, J, et al.. (1970). Effect of lipids on aminoacyl‐tRNA synthesis in Escherichia coli. FEBS Letters. 6(2). 86–88. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026